Maria Vallet-Regí is a chemist,scientist, and professor atUniversidad Complutensede Madrid, Spain. She isrecognized as a pioneer inthe field of ceramic materialsapplied to medicine. She was the pioneer who suggested introducing drugs intothe pores of mesoporous silica materials (MSMs), whichinspired thousands of publications worldwide involving MSNs for drug delivery. Her current research interest’s arefocused on developing nanomedicines for treating different diseases, such as bone infection, osteoporosis or bonecancer.She is a Highly Cited Researcher 2018 (Clarivate Analytics). Her publications have been cited over 47.000 times and her h-index is 102. Prof. Vallet-Regí has been awarded many important International prizes. She has an ERC Advanced Grant entitled “Polyvalent mesoporous nanosystem for bone diseases.

Professor Richard J. Spontak was a research scientist with Procter & Gamble before he joined the NCSU faculty in 1992. Spontak has over 104 publications in peer-reviewed journals, and his work has been featured on the cover of Microsc. Res. Tech. and Langmuir. Spontak conducts studies to improve the current understanding of microstructural polymer systems, which are of scientific interest as self-assembling polymers and commercial value as adhesives, (bio)compatibilizing agents, nanotemplates, and membranes. His group’s efforts are at the cutting edge of block copolymer research: e.g., they have obtained the first 3D images of the bicontinuous gyroid (Ia3d) and sponge (L3) morphologies. They characterize polymers with electronspectroscopic microscopy, and dispersions/gels with freeze-fracture replication and cryo-TEM techniques. Use of these tools has expedited the study of block copolymers and their blends/gels, and has helped to elucidate novel polymer gelation mechanisms, PDLC composition/morphology relationships, and interpolymer complexation. Other areas of interest include polymer alloying through mechanical attrition, transmission electron microtemography, and modification of polymer solutions via salting-in

CEO and Professor Nanotechnology & Regenerative Medicine Commercialization Centre (NanoRegMed Ltd) London BioScience Innovation Centre, London, United Kingdom Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver cancer. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. Recently he has commercialised a novel functionalised graphene oxide for medical and other industrial applications and synthetic graphene-based nanocomposite materials for surgical and medical devices application. He is currently working on the development of facial organs, heart valves and tendons.

Abraham J. Domb is a Professor for Medicinal Chemistry and Biopolymers at the School of Pharmacy- Faculty of Medicine and for Forensic Sciences at the faculty of Law of the Hebrew University of Jerusalem. He earned Bachelor’s degrees in Chemistry, Pharmaceutics and Law studies; Diplomas in Business management and Textile science and PhD degree in organic chemistry from The Hebrew University of Jerusalem. He did his postdoctoral training at MIT and Harvard Univ. Cambridge USA and was R&D manager at Nova Pharm. Co. Baltimore US during 1988-1991. Since 1991 he is a faculty member at the Hebrew university. During 2007-2012 he headed the Division of Forensic Science at the Israel Police, rank: Brigadier General. During 2014-2016 he served as president of the Jerusalem College of Engineering (JCE). Since 2018, he is the head of the School of Pharmacy of the Hebrew University. His research focus on pharmaceutics, medicinal chemistry and forensic science. His research resulted in several products, including: Gliadel,Superfloc, Inspace, Bioprotect, Canker Cover, OraMiost, Deximun and Maze.

Gedanken: Prof. (Em.) Aharon Gedanken obtained his M. Sc. from Bar-Ilan University, and his Ph. D. degree from Tel Aviv University, Israel. After his postdoctoral research at USC in Los Angeles. He got a lecturer position at BIU on Oct. 1975. He spent two sabbatical years at AT&T Bell Laboratories in 1980-8l, and 1987-88 as well as a summer in 1984. He also has done research at NIDDK, NIH in the summers of 1989, 1990 and 1991. In 1994 he switched his research interest from Spectroscopy to Nanotechnology. His special synthetic methods of nanomaterials include: Sonochemistry, Microwave Superheating, Sonoelectrochemistry, and Reactions under Autogenic Pressure at Elevated Temperatures (RAPET). Since 2004 he is mostly focused on the applications of nanomaterials. Gedanken has published 850 per-reviewed manuscripts in international journals and has applied for 42 Patents. His H-Index is 96 according to the WEB of SCIENCE and 109 according to Google Scholar. Gedanken has served as the Department Chairman as well as the Dean of the Faculty of Exact Sciences at Bar-Ilan University. He is on the editorial boards of 7 international journals. He still leads a group of 11 research people. He was a partner in five EC (European Community) FP7 projects one of them, SONO, was coordinated by him. This project was announced by the EC as a “Success Story”. He is a partner in PROTECT a textile project and BIOMAT in Horizon 2020. He was the Israeli representative to the NMP (Nano, Materials, and Processes) committee of EC in FP7. He was awarded the prize of the Israel Vacuum Society in 2009 and the Israel Chemical Society for excellence in Research in Feb. 2013. Two Start-up companies have emerged from his Patents, SONOVIA and NANO SONO.

Prof. Dimitrios I. Fotiadis (Male), received the Diploma degree in chemical engineering from the National Technical University of Athens, Athens, Greece, and the Ph.D. degree in chemical engineering and materials science from the University of Minnesota, Minneapolis. He is currently a Professor of Biomedical Engineering in the Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece, where he is also the Director of the Unit of Medical Technology and Intelligent Information Systems, and is also an Affiliated Member of Foundation for Research and Technology Hellas, Institute of Molecular Biology and Biotechnology, Dept. of Biomedical Research. He was a Visiting Researcher at the RWTH, Aachen, Germany, and the Massachusetts Institute of Technology, Boston. He has coordinated and participated in more than 250 R&D funded projects (in FP6, FP7, H2020, and national Projects), being the coordinator (e.g. INSILC, TAXINOMISIS, HOLOBALANCE, DECODE, etc.) and Technical coordinator (e.g. SMARTOOL, KARDIATOOL, TO_AITION, etc.). He is the author or coauthor of more than 300 papers in scientific journals, 500 papers in peer-reviewed conference proceedings, and more than 50 chapters in books. He is also the author/editor of 30 books. His work has received more than 16,000 citations (h-index=64). He is IEEE EMBS Fellow, EAMBES Fellow, Fellow of IAMBE, member of the IEEE Technical Committee of information Technology in Healthcare, Editor in Chief of IEEE Journal of Biomedical and Health Informatics, Member of the Editorial Board in IEEE Reviews in Biomedical Engineering, Associate Editor for IEEE Open Journal in Engineering in Biology and Medicine and Computers in Biology and Medicine. His research interests include multiscale modelling of human tissues and organs and implantable devices, intelligent wearable/implantable devices for automated diagnosis, processing of big medical data, machine learning, sensor informatics, image informatics, and bioinformatics. He is the recipient of many scientific awards including the one by the Academy of Athens. He is the co-founder of PD Neurotechnology Ltd, UK.

Cheryl Miller is a Professor of Biomaterials in The School of Clinical Dentistry at The University of Sheffield. She leads pioneering multidisciplinary research into new biomaterials and medical technologies. Principally the development of novel materials and medical devices with enhanced properties for dental and medical applications to improve both human health and quality of life. She has particular specialisation in the development of medical devices with dual action of enhanced bone regeneration and antimicrobial capabilities.

Prof. Jinlian HU is a smart polymer and textile materials scientist. Graduated with an MPhlil from Donghua University in textile materials and received a PhD from Manchester University, she recently joined the Department of Biomedical engineering, City University of Hong Kong where she established a Laboratory of Wearable Materials for Healthcare. The laboratory focuses on unearthing scientific principles and providing solutions to key problems in Healthcare of Wearable Materials in three major areas: Traditional Chinese medical therapies and their materials, energy materials and healthcare, spider silks and their relatives as biomaterials as well as personal protective integration . As such, we apply advanced methods including custom-made wearable electronics as basic tools to examine materials, their application methods, and particularly their interactions with human body in terms of physical, chemical, biological, philological and informational relations. From the discoveries and models of basic research, applied investigation, product developments and standardization are envisaged, which can produce societal as well economic impact in addition to scientific advances. Before CityU, professor Hu worked at Hong Kong Polytechnic University for more than 20 years. Professor Jinlian HU is a Fellow of the Royal Society of Chemistry, Hong Kong Institution of Textile and Apparel and the British Textile Institute. She is the founding chairman of the Hong Kong Health Science and Technology Park, the executive vice chairman of the Hong Kong Invention and Innovation Federation and a Council member of the Hong Kong Far Infrared Association

Dr. Nasim Nosoudi is an assistant professor in the Weisberg Division of Biomedical engineering at Marshall University. She holds a bachelor’s degree in Material Engineering. She has completed her master’s degree in Biomedcial engineering with a focus on Bone tissue engineering. She received her PhD in Bio-Engineering with a focus on Nanomedicine from Clemson University. She is interested in developing nanomedicine for cardiovascular diseases and reprogramming cells using electrospinning

Boris Gramatikov obtained his Dipl.-Ing. degree in Biomedical Engineering in Germany, and his Ph.D.in Bulgaria. He has completed a number of postdoctoral studies in Germany, Italy and the United States. He joined the faculty of the Biomedical Engineering Department of The Johns Hopkins University in 1996, andhas been working in the Laboratory of Ophthalmic Instrumentation Development at The Wilmer Eye Institutesince 2000. Areas of expertise include electronics, optoelectronics, computers, computer modeling, signal/image analysis, instrumentation design, biophotonics, ophthalmic and biomedical optics, polarization optics, all applied to the development of diagnostic methods and devices for ophthalmology and vision research.His team has developed a series of pediatric vision screeners. He has over 120 publications, 40 of which in high-impact peer-reviewed journals. He serves as a reviewer and editorial board member with a number of technical and medical journals.Member of the Continuing Education Committee of the IEEE.

Ilaria Ottonelli was born in northern Italy, and moved to Modena, Emilia Romagna, where she graduated in Medicinal Chemistry at the University of Modena and Reggio Emilia. During her thesis, she spent six months abroad studying at Ulm University, Germany, where she gained experience with animal models and learned how to manipulate animal tissues for imaging purposes. She graduated in 2018 with top honors and entered the PhD Program of Clinical and Experimental Medicine in the laboratory of Dr. Giovanni Tosi in 2019. As a PhD student, Ilaria Ottonelli’s research is focused on the optimization of polymeric nanoparticles loaded with different therapeutic molecules. She actively collaborates with different laboratories in Europe to test therapeutic efficacy of her results in vitro and in vivo, focusing on retinal delivery, blood-brain barrier targeting, neurodegenerative diseases, and trafficking of nanoparticles via tunneling nanotubes.

Francisco Eliseo Jaramillo Torres was born in Quito on April 11 of 1994. He studied at the high school in Instituto Nacional Mejia and got the specialization of physical mathematician in 2012, then he studied the college in Yachay Tech University and got the title of Biomedical Engineer in May of 2020. His thesis was based on the biosynthesis of selenium nanoparticles using the microalga Chlamydomonas reinhardtti. On July 16 of 2020, he published his first collaboration in the article titled “In Vivo Biosynthesis of Inorganic Nanomaterials Using Eukaryotes” in Molecules. This year he started by publishing a second article titled “Green Synthesis of Selenium and Tellurium Nanoparticles: Current Trends, Biological Properties, and Biomedical Applications” in the Molecular Sciences journal.